Klas Petersson

Statistics

Publications

Citations

H-Index

Active since

2009

Affiliations

AstraZeneca (South Korea)(Current)

AstraZeneca (United States)

AstraZeneca (Singapore)

AstraZeneca (Poland)

AstraZeneca (Brazil)

Klas Petersson is an author at AstraZeneca (South Korea) specializing in cell line-derived xenograft models, pharmacokinetics of anticancer drugs, and curve fitting.

ORCID

Publications per year

2009–2023

Publications

Semiparametric Distributions With Estimated Shape Parameters

Klas Petersson, Eva Hanze, Radojka M. Savić et al. · Pharmaceutical Research · 2009 · 69 citations

Natural Sciences, Biostatistics, Statistical Modeling +12

A pharmacokinetic–pharmacodynamic model for the MET tyrosine kinase inhibitor, savolitinib, to explore target inhibition requirements for anti‐tumour activity

Rhys D.O. Jones, Mike Grondine, Alexandra Borodovsky et al. · British Journal of Pharmacology · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16

Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation–Positive, MET-Amplified Non–Small Cell Lung Cancer Model

Rhys D.O. Jones, Klas Petersson, Areya Tabatabai et al. · Molecular Cancer Therapeutics · 2023 · 11 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

1–3 of 3